In our North of England inherited optic neuropathy cohort, DOA+ phenotypes were observed in 1 in 6 OPA1 carriers, which clearly indicate that these syndromal variants affect a significant patient subgroup (Yu-Wai-Man et al., 2010a). This evidence concerns the gene OPA1 and optic nerve disorder.